Subscribe to Entomopharm News
-
News
- Lundbeck will present data at the 4th International Conference Clinically Relevant Drug Transporters – 22 – 23 April, 2013 in Berlin
- Have you read most recent review ‘Novel models for assessing blood–brain barrier drug permeation’
- The project “Insect Models for Drug Discovery” has received funding from the Danish National Advanced Technology Foundation
- The Scientific Advisory Board
- Description of the Locust BBB models in Drug Discovery Today
Category Archives: News
Lundbeck will present data at the 4th International Conference Clinically Relevant Drug Transporters – 22 – 23 April, 2013 in Berlin
Recent data obtained by using our optimized model will be presented by Lundbeck in Berlin at the 4th International Conference Clinically Relevant Drug Transporters – 22 – 23 April, 2013. In summary the data show: that our ex vivo grasshopper … Continue reading
Posted in News
Leave a comment
The project “Insect Models for Drug Discovery” has received funding from the Danish National Advanced Technology Foundation
The vision of the project is to establish insects, as a novel model organism in preclinical research. EntomoPharm has previously developed two models for ADME drug screening in locusts. From this work and from preliminary insect studies it is evident … Continue reading
Posted in News
Leave a comment
The Scientific Advisory Board
We are proud to present Entomopharm’s newly established Scientific Advisory Board: The Scientific Advisory Board for EntomoPharm consists of international researchers from academia, biotech and pharmaceutical industry. The objective of the scientific advisory board is to provide independent advice and … Continue reading
Posted in News
Leave a comment
Description of the Locust BBB models in Drug Discovery Today
Models for predicting blood-brain barrier permeation. Nielsen PA, Andersson O, Hansen SH, Simonsen KB, Andersson G (2011). Drug Discovery Today, June; 16(11-12):472-5
Posted in News
Leave a comment
The Danish Growth Fund invests in EntomoPharm
The Danish Growth Fund (Vaekstfonden) has invested series A venture capital into EntomoPharm to support our commercialization efforts.
Posted in News
Comments Off